asthma
Sensors described in the European Patent Office filing could be placed underneath the user's mattress or pillow.
At the MEDinIsrael conference in Tel Aviv, Director of Analytics and Big Data Dr. Lena Granovsky talked about technology, big data, and analytics' growing role at the company.
The Fenom Pro Asthma Monitor will let clinicians measure the fraction of exhaled nitric oxide in their patient's breath.
While connected devices currently reign supreme, authors of the report see a market opportunity for new players offering a purely digital service.
Users will be able to make refill requests, locate pharmacies, and even chat with a pharmacist without leaving Propeller's app.
The prescription device detects each use and records it to a paired mobile app.
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma.
A partnership between Louisville, Kentucky city leaders, a non-profit, and digital respiratory health company Propeller Health has led to clear improvements in local asthmatic residents’ inhaler use and symptoms, according to a study recently published in Health Affairs.
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.